Licorice-Derived Glycyrrhizin Points to New IBD Therapy

Researchers used a lab-grown human intestinal model to screen about 3,500 compounds for treating inflammatory bowel disease (IBD). Glycyrrhizin, a compound from black licorice, emerged as a strong candidate, reducing intestinal cell death and inflammation in the model and showing similar protective effects in mice, indicating potential for clinical development pending further studies.